Skip to Content
Gilead Shows the Dangers of Covid-19 Drug Mania — Heard on the Street
Janssen Pharma Says FDA Approves Stelara for Pediatric Patients
Johnson & Johnson: Covid-19 Vaccine Candidate Elicits Strong Immune Response in Pre-Clinical Studies
Johnson & Johnson starts trial of COVID-19 vaccine after producing immune response in primates
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
Janssen Gets CHMP Positive Opinion for Expanded Use of Imbruvica in Combination with Rituximab
Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO®
This index ETF is beating the S&P 500 by excluding 'losers'
Democratic lawmakers signal concern about coronavirus vaccine pricing, speed of development
Johnson & Johnson On Pace for Longest Winning Streak Since June 2019 — Data Talk
